In the latest episode of our Gamechangers video series, Professor John Buse talks about a paper that he thinks will transform the way we manage #diabetes in years to come. More Gamechangers episodes:

When a country faces war or natural disaster, it will face unique challenges in caring for its population with diabetes. Read our report from #EASD2023 on the challenges faced by people with #diabetes in Yemen, Iraq and Syria. 👉

RT @DiabetesCareADA: We found a disruption to the seasonal pattern but no overall increase in the expected incidence of pediatric diabetes…

RT @TheLancet: People with diabetes often encounter stigma which can adversely affect their health. In @TheLancetEndo, authors call on the…

RT @TheLancetEndo: These data define pathophysiological underpinnings of the tree structure, which has the potential to stratify #diabetes-…

5 things we don't yet know...about #diabetes Take a look at our video series with leading researchers talking about the big research questions that still need to be answered. 👉

RT @moreno_perez_o: 🚨🚨🚨Real‐world effectiveness and safety of oral semaglutide in people living with T2D: A nationwide multicentre retrospe…

RT @DiabetesCareADA: Psychosocial care for people with diabetic neuropathy needs attention from both clinicians and researchers: a call for…

RT @DiabetesCareADA: Both continuous and intermittently scanned continuous glucose monitoring provide significant reductions in HbA1c compa…

In our clip of the week, Professor John Buse discusses the paper that could change the future of screening for type 1 #diabetes. #T1D Full clip on our site:

RT @docwas: Our paper Inequalities the management of diabetic kidney disease in UK primary care: A cross‐sectional analysis of a large prim…

When a country faces war or natural disaster, it will face unique challenges in caring for its population with diabetes. Read our report from #EASD2023 on the challenges faced by people with #diabetes in Yemen, Iraq and Syria 👉

RT @DiabetologiaJnl: #GLP1ReceptorAgonists are associated with lower incidences of adverse cardiovascular events and all-cause mortality in…

RT @DiabetologiaJnl: Everything you need when designing a study to investigate hepatic glucose uptake with FDG PET: getting us one step clo…

RT @kamleshkhunti: Meta-analysis 54 RCTs & 32 cohort studies SGLT2 inhibitors significantly ⬇️ MI incidence in RCTs & cohort studies Ca…

RT @parthaskar: ‘A blog to show case 10 folks or groups who –in my opinion-deserve a mention for their work which has helped many with #Dia…

RT @Filip_Knop: Here, the brilliant Patrik Rorsman and team from @ocdem, @SahlgrenskaAcad and @OxfordBRC show the GLP-1 derivative GLP-1(9–…

Clip of the week: Professor John Buse chooses a gamechanging paper that he thinks will transform the way we manage #diabetes in years to come. Full clip:

RT @AmarPut: Risk Factors for Young-Onset Dementia in the UK Biobank 15 risk factors identified, yep diabetes in there 😉 but a few intere…

New findings from SURPASS were presented at #EASD2023, revealing that tirzepatide comes with some extra benefits. #Diabetes Read our report: